About Index Trending news
Analyze
Pricing
Oryzon Genomics

Oryzon Genomics

Oryzon Genomics

Oryzon Genomics develops diagnostic and therapeutic tools based on identifiedbiomarker genes and proteins.

Elsewhere

Alexa global traffic share

31 Mar 2017
€18,000,000
Post-IPO equity

Oryzon Raises EUR 18 Million through a Private Placement with US and European Investors

Marketwire
+1
12 Mar 2008
$17,024,700
Venture capital (Series B)